Sulfuretin protects against cytokine-induced beta-cell damage and prevents streptozotocin-induced diabetes.
10.3858/emm.2010.42.9.062
- Author:
Mi Young SONG
1
;
Gil Saeng JEONG
;
Kang Beom KWON
;
Sun O KA
;
Hyun Young JANG
;
Jin Woo PARK
;
Youn Chul KIM
;
Byung Hyun PARK
Author Information
1. Department of Biochemistry, Medical School and Diabetes Research Center, Chonbuk National University, Jeonju 561-756, Korea. bhpark@chonbuk.ac.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
cytokines;
diabetes mellitus, experimental;
NF-kappaB;
Rhus verniciflua;
streptozotocin;
sulfuretin
- MeSH:
Animals;
Benzofurans/*pharmacology/therapeutic use;
Cell Line;
Cytokines/*adverse effects;
Diabetes Mellitus, Experimental/drug therapy/*prevention & control;
Flavonoids/pharmacology/therapeutic use;
Hypoglycemic Agents/pharmacology/therapeutic use;
Insulin-Secreting Cells/*drug effects;
Male;
Mice;
Mice, Inbred ICR;
NF-kappa B/*metabolism;
Rats;
Rats, Sprague-Dawley;
Rhus/chemistry
- From:Experimental & Molecular Medicine
2010;42(9):628-638
- CountryRepublic of Korea
- Language:English
-
Abstract:
NF-kappaB activation has been implicated as a key signaling mechanism for pancreatic beta-cell damage. Sulfuretin is one of the main flavonoids produced by Rhus verniciflua, which is reported to inhibit the inflammatory response by suppressing the NF-kappaB pathway. Therefore, we isolated sulfuretin from Rhus verniciflua and evaluated if sulfuretin could inhibit cytokine- or streptozotocin-induced beta-cell damage. Rat insulinoma RINm5F cells and isolated rat islets were treated with IL-1beta and IFN-gamma to induce cytotoxicity. Incubation of cells and islets with sulfuretin resulted in a significant reduction of cytokine-induced NF-kappaB activation and its downstream events, iNOS expression, and nitric oxide production. The cytotoxic effects of cytokines were completely abolished when cells or islets were pretreated with sulfuretin. The protective effect of sulfuretin was further demonstrated by normal insulin secretion of cytokine-treated islets in response to glucose. Treatment of mice with streptozotocin resulted in hyperglycemia and hypoinsulinemia, which was further evidenced by immunohistochemical staining of islets. However, the diabetogenic effects of streptozotocin were completely prevented when mice were pretreated with sulfuretin. The anti-diabetogenic effects of sulfuretin were also mediated by suppression of NF-kappaB activation. Collectively, these results indicate that sulfuretin may have therapeutic value in preventing beta-cell damage.
